Additionally, in a NSCLC model, the combination of prostate stem cell antigen (PSCA)- and MUC1-targeting CAR-T cells synergistically eliminated PSCA+ and MUC1+ cancer cells [89]. This evidence concerns the gene MUC1 and cancer.